Benjamin James Daverman
CIK: 0001829768
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
Director
Discretionary Trading P&L
Holdings
About DAVERMAN BENJAMIN JAMES
DAVERMAN BENJAMIN JAMES (SEC CIK 0001829768) files insider reports with the SEC as Director of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
Signal8 holds 1 ownership filing by DAVERMAN BENJAMIN JAMES, a Form 4, filed on Jun 18, 2025. Those filings report 1 transaction, the latest on Jun 16, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on DAVERMAN BENJAMIN JAMES's filings is in CHICAGO, IL.
Recent filings by DAVERMAN BENJAMIN JAMES
- Jun 16, 2025: Grant or award of MRVI shares (Form 4, code A).
Other insiders filing for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
- Asarpota Rajesh, Chief Financial Officer
- Brust Bernd, Chief Executive Officer
- ORESHACK KURT, General Counsel
- LUCIER GREGORY T, Director
- MARKER LUKE JOSEPH, Director
- GRAY SUSANNAH, Director